Erlotinib Completed Phase 3 Trials for Metastatic Colorectal Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00598156Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- Tarceva